Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?

  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Capilla, Silvia|||0000-0002-7274-2973
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Espasa, Mateu|||0000-0003-4822-1024
  • Novais, Carla|||0000-0002-3826-6731
  • Miró, José M.|||0000-0001-8057-7755
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Gasch, Oriol|||0000-0001-8518-458X
Objectives: Enterococcus faecium, a significant hospital associated pathogen, poses substantial treatment challenges. While combinations of ampicillin with cephalosporins are first-line therapies to treat Enterococcus faecalis high-mortality-rates infections, their efficacy against ampicillin-susceptible E. faecium (ASEfm) is less clear. This study evaluates the effectiveness of combining ampicillin with ceftriaxone or ceftaroline against ASEfm strains. Methods: Ten ASEfm bloodstream isolates from complicated infections were analyzed. Susceptibility to several antibiotics, including ceftriaxone, ceftaroline, and cefotaxime, was determined using standard methods. Time-kill assays were conducted to assess the synergistic and additive effects of ampicillin in combination with ceftriaxone or ceftaroline. Results: Time-kill studies revealed that ampicillin combined with ceftaroline demonstrated synergistic and/or additive effects in 7 out of 10 strains analyzed. In contrast, ampicillin combined with ceftriaxone showed less pronounced synergy, with only 3 out of 10 strains exhibiting synergistic and/or additive effects. Conclusions: Our findings indicate that ampicillin combined with ceftaroline, or ceftriaxone provides synergistic activity against some but not all ASEfm clinical isolates. The observed synergy suggests that these combinations could offer a potential therapeutic option for challenging ASEfm infections.
Repisalud
Publicación Artículo científico (JournalArticle)

Characterization of OXA-48-producing Klebsiella oxytoca isolates from a hospital outbreak in Tunisia.

  • Guzmán-Puche, Julia
  • Jenayeh, Rim
  • Perez-Vazquez, Maria
  • Causse, Manuel
  • Asma, Ferjani
  • Jalel, Boukadida
  • Oteo-Iglesias, Jesus
  • Martínez-Martínez, Luis
There is very limited information about OXA-48-producing Klebsiella oxytoca. The aim of this study was to describe the phenotypic and molecular characterization of OXA-48-producing K. oxytoca isolates that caused an outbreak in a hospital in Tunisia. Nineteen OXA-48-producing K. oxytoca were isolated from 2013 to 2016 in the University Hospital Farhat Hached, Sousse, Tunisia. Antibiotic susceptibility testing was performed by broth microdilution. Carbapenemase activity was investigated using the modified carbapenem inactivation method (mCIM). Phenotypic tests were also carried out to detect extended-spectrum β-lactamases. PCR was used to test for the presence of carbapenemase genes (blaIMP, blaVIM, blaNDM, blaSPM, blaAIM, blaDIM, blaGIM, blaSIM, blaKPC, blaBIC and blaOXA-48). Genetic relatedness among isolates was investigated using rep-PCR. Whole genome sequencing (WGS) was performed in three representative isolates. mCIM was positive in all isolates. None of the isolates presented an ESBL phenotype. All strains were susceptible to cefoxitin, ceftazidime, cefepime, aztreonam, imipenem, meropenem, fluoroquinolones, aminoglycosides and colistin, and resistant to piperacillin-tazobactam, ertapenem, ticarcillin and ampicillin-sulbactam. All isolates presented the blaOXA-48 gene located in a ca. 63 kb IncL plasmid, which carried no additional resistance genes. They belonged to the new ST220. Isolates from this study did not co-express an ESBL, which could complicate their detection in clinical laboratories. As OXA-48 has been mostly reported in K. pneumoniae there is a risk that the production of this enzyme is not suspected in the less common species K. oxytoca. These difficulties could play an important role in the hidden spread of this enzyme.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

EXPLORACIÓN DE CARACTERÍSTICAS CONCEPTUALES EN CONTEXTOS RICOS EN CONOCIMIENTO MEDIANTE UN PROGRAMA DE ANÁLISIS CUALITATIVO

  • Valero Doménech, Esperanza
  • Alcina Caudet, Amparo
[EN] In this study we analyzed the dictionary defi nitions and defi nitory contexts extracted from a corpus of the ceramic fi eld. The objective was to discover the relevant features in the description of the concept groups: ceramic defects and ceramic production processes. In order to segment and classify the fragments which contain a conceptual feature, we used a program for the qualitative analysis. The results consist in a set of relevant features for the description of the two groups analyzed one the one hand, and the fragments of text associated with each of these features on the other. The qualitative analysis program has proved effi cient in this study given its effi cacy to manage and retrieve data., [ES] En este trabajo hemos analizado definiciones de diccionarios y contextos definitorios extraídos de un corpus del campo de la cerámica para obtener las características relevantes en la descripción de los grupos de conceptos: defectos del producto cerámico y procesos de fabricación. Para segmentar y clasificar aquellos fragmentos de texto que describían una característica conceptual, hemos utilizado un programa de análisis cualitativo. Los resultados de este análisis son, por un lado, el conjunto de características relevantes para la descripción de los dos grupos analizados y, por otro, los fragmentos de texto asociados a cada una de estas características. El programa de análisis cualitativo ha resultado muy útil para este trabajo, por su eficacia para gestionar y recuperar datos., ONTODIC: Metodología y tecnologías para la elaboración de diccionarios onomasiológicos basados en ontologías. Recursos terminológicos para la e-traducción, proyecto fi nanciado por el Gobierno de España (TSI2006-01911). ONTODIC II: Metodología y tecnologías para la elaboración de diccionarios de colocaciones basados en ontologías. Recursos terminológicos para la e-traducción, proyecto fi nanciado por el Gobierno de España (TIN2009-07690).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metal utilization in genome-reduced bacteria, Do human mycoplasmas rely on iron?

  • Peralvarez-Marin, Alex|||0000-0002-3457-0875
  • Baranowski, Eric|||0000-0003-0660-1854
  • Bierge, Paula|||0000-0003-0917-3445
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Lebrette, Hugo
Mycoplasmas are parasitic bacteria with streamlined genomes and complex nutritional requirements. Although iron is vital for almost all organisms, its utilization by mycoplasmas is controversial. Despite its minimalist nature, mycoplasmas can survive and persist within the host, where iron availability is rigorously restricted through nutritional immunity. In this review, we describe the putative iron-enzymes, transporters, and metalloregulators of four relevant human mycoplasmas. This work brings in light critical differences in the mycoplasma-iron interplay. Mycoplasma penetrans, the species with the largest genome (1.36 Mb), shows a more classic repertoire of iron-related proteins, including different enzymes using iron-sulfur clusters as well as iron storage and transport systems. In contrast, the iron requirement is less apparent in the three species with markedly reduced genomes, Mycoplasma genitalium (0.58 Mb), Mycoplasma hominis (0.67 Mb) and Mycoplasma pneumoniae (0.82 Mb), as they exhibit only a few proteins possibly involved in iron homeostasis. The multiple facets of iron metabolism in mycoplasmas illustrate the remarkable evolutive potential of these minimal organisms when facing nutritional immunity and question the dependence of several human-infecting species for iron. Collectively, our data contribute to better understand the unique biology and infective strategies of these successful pathogens.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genomic analysis of Staphylococcus aureus isolates from bacteremia reveals genetic features associated with the COVID-19 pandemic

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Pedrosa, Marc|||0000-0001-6355-4121
  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Alguacil Guillen, Marina|||0000-0003-1530-013X
  • Espasa, Mateu|||0000-0003-4822-1024
  • Erill, Ivan|||0000-0002-7280-7191
  • Gasch, Oriol|||0000-0001-8518-458X
  • Pich, Oscar Q.|||0000-0003-3561-630X
Genomic analyses of bacterial isolates are effective to compare the prevalence of antibiotic resistance genes and virulence determinants in different contexts. This study provides a comprehensive genomic description of 339 Staphylococcus aureus strains isolated from patients with bacteremia (2014-2022). Nosocomial acquisition accounted for 56.6% of cases, with vascular catheters being the main infection source (31.8%). Fatality (27.4%), persistent bacteremia (19.5%), and septic emboli (24.2%) were documented. During the COVID-19 pandemic, S. aureus bacteremia episodes increased by 140%. Genetic features in pandemic isolates revealed higher prevalence of methicillin (mecA) and macrolide (msrA and mphC) resistance genes. Additionally, genes encoding clumping factors A and B, involved in fibrinogen binding, were more prevalent. This was linked to extensive macrolide use in COVID-19 accessory therapy and elevated fibrinogen levels in SARS-CoV-2 infection. These findings highlight S. aureus adaptation to COVID-19 selective pressures and the value of whole-genome sequencing in molecular epidemiology studies.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Androgen receptor and fatty acid oxidation cooperate in ferroptosis evasion in BRAFi resistant melanoma

  • Redondo Muñoz, Marta
  • Caballé-Mestres, Adrià
  • Reisz, Julie A.
  • Valero-Leria, Ane
  • Olías Arjona, Ana
  • Aldaz Donamaría, Paula
  • D´Alessandro, Angelo
  • Wellbrock, Claudia
  • Arozarena Martinicorena, Imanol
Melanoma accounts for over 85% of all skin cancer deaths. Current therapies including drugs targeting BRAF and MEK significantly improve the prognosis of metastatic melanoma patients, yet innate or acquired resistance challenges long-term responses. We have shown previously that fatty acid beta-oxidation (FAO) is up-regulated during the acquisition of BRAF-inhibitor (BRAFi) resistance and that the FDA approved drug ranolazine, by targeting FAO attenuates the development of acquired resistance. However, how ranolazine-induced metabolic rewiring increases cell death is unclear. Here we identify ranolazine as a ferroptosis inducer in BRAFi-resistant melanoma, in which FAO serves as a ferroptosis surveillance mechanism. Accordingly, in progressed tumours of BRAFi treated patients up-regulation of FAO regulators correlates with increased expression of ferroptosis markers. BRAFi resistant cells are heavily poised for execution of ferroptosis; they display reduced glutathione levels, higher levels of long-chain polyunsaturated fatty acid (PUFA) membrane-incorporation, and increased membrane-resident phospholipid oxidation, all of which is amplified by ranolazine. Counteracting ranolazine action is MBOAT1/2 mediated phospholipid remodelling, which initiates reduced PUFA membrane-incorporation as ferroptosis surveillance mechanism. We show that the androgen receptor (AR), which is a determinant of BRAFi resistance, controls MBOAT1/2 expression, thereby contributing to ferroptosis resistance. In BRAFi resistant tumours and cell lines, we confirm AR upregulation predominantly in the MITFlow/AXLhigh undifferentiated/neural-crest like state, but it also occurs in the MITFhigh/AXLlow differentiated melanocytic state. The AR antagonist enzalutamide sensitises AR expressing melanoma cells to RSL3 and erastin independent of phenotype state, but in FAOhigh BRAFi relapsed tumours AR up-regulation correlates with the undifferentiated/neural-crest like (UD/NC) state, and enzalutamide synergises with ranolazine in ferroptosis-induction in UD/NC cells. Thus, therapeutically combining ranolazine with the AR inhibitor enzalutamide to induce ferroptosis can circumvent dedifferentiation related BRAFi resistance and could increase therapeutic activity and long-term efficacy., I.A. and P.A. acknowledge funding from the Ministry of Economy and Competitiveness (Institute of Health Carlos III-ISCIII; refs. PI19/00645 to I.A., PI16-01911 to I.A., CPII20/00011 to I.A., CD21/00137 to P.A. I.A. and A.V.L are also funded by Departamento de Salud del Gobierno de Navarra, Spain (refs. G°Na 71/17 and GN2024-54). I.A. and M.R.M. acknowledge funding from The Spanish Association against Cancer (AECC; PRYES223349AROZ). M.R.M. was funded by a PhD studentship from the Department of Industry of the Government of Navarra, Spain, by the Grupo Español Multidisciplinar de Melanoma and the Asociación Española Contra el Cáncer. P.A. was funded by a Sara Borrell contract from ISC-III. The University of Colorado School of Medicine Metabolomics Core is supported in part by the University of Colorado Cancer Centre award from the National Cancer Institute P30CA046934.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma

  • Lasheras Otero, Irene
  • Feliu, Iker
  • Maíllo Ruiz de Infante, Alberto
  • Moreno, Haritz
  • Redondo Muñoz, Marta
  • Aldaz Donamaría, Paula
  • Bocanegra Gondán, Ana Isabel
  • Olías Arjona, Ana
  • Lecanda, Fernando
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • Larráyoz, Ignacio M.
  • Gómez-Cabrero, David
  • Wellbrock, Claudia
  • Vicent, Silvestre
  • Arozarena Martinicorena, Imanol
Circulating tumor cells are the key link between a primary tumor and distant metastases, but once in the bloodstream, loss of adhesion induces cell death. To identify the mechanisms relevant for melanoma circulating tumor cell survival, we performed RNA sequencing and discovered that detached melanoma cells and isolated melanoma circulating tumor cells rewire lipid metabolism by upregulating fatty acid (FA) transport and FA betaoxidation‒related genes. In patients with melanoma, high expression of FA transporters and FA beta-oxidation enzymes significantly correlates with reduced progression-free and overall survival. Among the highest expressed regulators in melanoma circulating tumor cells were the carnitine transferases carnitine O-octanoyltransferase and carnitine acetyltransferase, which control the shuttle of peroxisome-derived medium-chain FAs toward mitochondria to fuel mitochondrial FA beta-oxidation. Knockdown of carnitine O-octanoyltransferase or carnitine acetyltransferase and short-term treatment with peroxisomal or mitochondrial FA beta-oxidation inhibitors thioridazine or ranolazine suppressed melanoma metastasis in mice. Carnitine O-octanoyltransferase and carnitine acetyltransferase depletion could be rescued by medium-chain FA supplementation, indicating that the peroxisomal supply of FAs is crucial for the survival of nonadherent melanoma cells. Our study identifies targeting the FA-based cross-talk between peroxisomes and mitochondria as a potential therapeutic opportunity to challenge melanoma progression. Moreover, the discovery of the antimetastatic activity of the Food and Drug Administration‒approved drug ranolazine carries translational potential., This work was funded by the Instituto de Salud Carlos III-FEDER through PI16-01911 and PI19/00645 to IA. IA and IML acknowledge support through Miguel Servet II fellowships (CPII20/00011 and CPII20/00029). The Health Department of the Government of Navarra, Spain funded work through reference GºNa 71/17. SV is funded by FEDER/Ministerio de Ciencia, Innovación y Universidades - Agencia Estatal de Investigación (PID2020-116344-RB-100) and by Foundation Spanish Association Against Cancer (PROYE20029VICE). ILO is funded through a Navarrabiomed PhD studentship and the Grupo Español Multidisciplinar de Melanoma (reference Beca_GEM). FL was funded by the Cancer Research Thematic Network of the Instituto de Salud Carlos III (RTICC RD12/0036/0066, SAF2015-71606R, RTI2018-094507-B-100) financed by MCIN/AEI/10.13039/501100011033 and by FEDER. FL was also funded by the la Caixa Foundation, Caja Navarra Foundation, and the Foundation AECC. PA is a recipient of a Sara Borrell postdoctoral fellowship from the Instituto de Salud Carlos III (CD21/00137).